Literature DB >> 20228852

Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis.

A Okamura, M Shimoyama, S Ishii, K Wakahashi, N Asada, H Kawano, Y Kawamori, S Nishikawa, K Minagawa, Y Katayama, T Matsui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20228852     DOI： 10.1038/bmt.2010.59

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis.

Authors:  Atsuo Okamura; Kimikazu Yakushijin; Yumiko Inui; Yohei Funakoshi; Yuriko Kawamori; Takanobu Shimada; Masanori Toyoda; Naoko Chayahara; Naomi Kiyota; Yutaka Fujiwara; Toru Mukohara; Hiroshi Matsuoka; Katsuya Yamamoto; Hironobu Minami
Journal:  Int J Hematol       Date:  2011-04-22       Impact factor: 2.490

2.  Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation.

Authors:  Kanako Wakahashi; Motohiro Yamamori; Kentaro Minagawa; Shinichi Ishii; Shinichirou Nishikawa; Manabu Shimoyama; Hiroki Kawano; Yuko Kawano; Yuriko Kawamori; Akiko Sada; Toshimitsu Matsui; Yoshio Katayama
Journal:  Int J Hematol       Date:  2011-07-14       Impact factor: 2.490

3.  Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.

Authors:  Stephen Harnicar; Doris M Ponce; Patrick Hilden; Junting Zheng; Sean M Devlin; Marissa Lubin; Melissa Pozotrigo; Sherry Mathew; Nelly Adel; Nancy A Kernan; Richard O'Reilly; Susan Prockop; Andromachi Scaradavou; Alan Hanash; Robert Jenq; Marcel van den Brink; Sergio Giralt; Miguel A Perales; James W Young; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2015-02-14       Impact factor: 5.742

4.  Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantation.

Authors:  Hiroyuki Muranushi; Junya Kanda; Yasuyuki Arai; Takero Shindo; Masakatsu Hishizawa; Takashi Yamamoto; Tadakazu Kondo; Kohei Yamashita; Kazuo Matsubara; Akifumi Takaori-Kondo
Journal:  Br J Clin Pharmacol       Date:  2020-05-30       Impact factor: 4.335

5.  Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms.

Authors:  Jaime Sanz; John E Wagner; Miguel A Sanz; Todd DeFor; Pau Montesinos; Veronika Bachanova; Ignacio Lorenzo; Erica Warlick; Guillermo F Sanz; Claudio Brunstein
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-30       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.